Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

Singapore-Johor VTL resumes with COVID-19 test results issued by Jebhealth

SINGAPORE, Feb. 8, 2022 /PRNewswire/ -- With the resumption of the land VTL betweenSingapore and Johor Bahru on Jan 21, about 2,000 travellers are expected to cross the causeway each day, in hope that we can eventually scale up to the normal 300,000 daily commutes. Many would be meeting their lov...

2022-02-08 07:00 3070

mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN

Researchers at Fox Chase Cancer Center conducted the largest published, peer-reviewed, study to-date examining the short-term adverse effects of mRNA COVID-19 vaccination in patients with cancer—finding they experienced no more, and no different, side effects compared to non-cancer patients. PLY...

2022-02-08 05:11 2000

Covaris AFA-energetics™ Enables True Automated Total Nucleic Acid Extraction and Purification Workflows from FFPE Tissues

A fully automated, high-throughput deparaffinization and total Nucleic Acids extraction and purification kit for FFPE samples WOBURN, Mass., Feb. 7, 2022 /PRNewswire/ -- Covaris, LLC ("Covaris" or "the Company"), a manufacturer of advanced tools enabling life science innovations, announced the l...

2022-02-07 23:00 2638

Ascletis Announces Positive Data of Oral Double Prodrug ASC10 and Its Antiviral Nucleoside Analog ASC10-A Against Omicron Variant

* ASC10-A demonstrated strong in vitro antiviral activity against multiple SARS-CoV-2 virus variants including Omicron * By applying a double prodrug strategy, ASC10's permeability in Caco-2 cells and ASC10's oral bioavailability in monkeys were 3.2-fold and 2.3-fold of Molnupiravir, respecti...

2022-02-07 19:00 2356

'2022 Sunhak Peace Prize Focuses on Vaccine Equity'

SEOUL, South Korea, Feb. 7, 2022 /PRNewswire/ -- On February 7, 2022, the Sunhak Peace Prize Committee (ChairmanJose Manuel Barroso, former President of the European Commission) will announce the 2022 Sunhak Peace Prize laureates are DameSarah Catherine Gilbert (age 59), Professor of Vaccinology ...

2022-02-07 18:00 2521

'2022 Sunhak Peace Prize Focuses on Vaccine Equity'

Clarivate Identifies Seven Medtech Trends to Watch in 2022

LONDON, Feb. 7, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new report,Outlook on the Medtech Industry: Seven Areas to Watch. The report analyzes seven factors that Clarivate ...

2022-02-07 16:00 1794

Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule CD73 Inhibitor ATG-037

SHANGHAI and HONG KONG, Feb. 7, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and o...

2022-02-07 08:30 2494

The one-component Sputnik Light vaccine has been authorized in India; over 2.5 billion people live in countries that approved Sputnik Light as a standalone vaccine and a universal booster

Sputnik Light will be an important part of India's vaccination program and the fight against mutations of COVID, including Omicron. Sputnik Light has been authorized in more than 30 countries with total population of over 2.5 billion people. MOSCOW, Feb. 7, 2022 /PRNewswire/ -- The Russian Dir...

2022-02-07 08:18 2628

Everest Medicines Announces First Drug Approval of Trodelvy® in Singapore for Second-Line Metastatic Triple-Negative Breast Cancer

SHANGHAI, Feb. 7, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs inAsia...

2022-02-07 08:00 2991

Ascletis Announces U.S. IND Approval of Oral PD-L1 Small Molecule Inhibitor ASC61 for Treatment of Advanced Solid Tumors

* The objectives of the U.S. Phase I trial are to find a recommended Phase II dose and obtain preliminary efficacy in patients with advanced solid tumors * The first U.S. patient is expected to be dosed in the first half of 2022 * ASC61 shows significant antitumor efficacy as a single agent i...

2022-02-06 18:30 3290

Vitro S.A. sells Cytognos to BD to prioritize the market launch of their new and disruptive Molecular Biology and Anatomic Pathology diagnostic platforms

Cytognos divestment is a first strategic step aimed at positioning Vitro as a new worldwide diagnostic player in their key market segments SEVILLE, Spain, Feb. 4, 2022 /PRNewswire/ -- Vitro S.A, (www.vitro.bio ) a privately held company headquartered in Seville, Spain, ann...

2022-02-04 17:23 4098

Invitation to the presentation of Elekta's third quarter 2021/22

STOCKHOLM, Feb. 4, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the third quarter 2021/22 at10:00 a.m. CET on February 24. The interim report for the third quarter will be published at 7:30 a.m. CET on the same day. The company's development will be...

2022-02-04 15:57 3399

Nanoform signs GMP manufacturing program with TargTex following formulation success

HELSINKI, Feb. 4, 2022 /PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, today announced it has signed a GMP1 manufacturing program (clinical development) to enhance TargTex's Glioblastoma multiforme drug candidate. The program starts with a PoP (Proof of Process) ph...

2022-02-04 15:54 3045

NCCN Joins the Call to 'Close the Care Gap' on World Cancer Day

Global nonprofit National Comprehensive Cancer Network participates in annual awareness day, highlighting cancer care disparities and free resources to help, detailed at NCCN.org/wcd. PLYMOUTH MEETING, Pa., Feb. 4, 2022 /PRNewswire/ -- World Cancer Day is observed everyFebruary 4. This year, the...

2022-02-04 13:37 2381

Wolters Kluwer Lauded by Frost & Sullivan for Enabling Aligned Decision-making with Its Clinical Decision Support Solutions

SAN ANTONIO, Feb. 3, 2022 /PRNewswire/ -- Frost & Sullivan recently assessed the North American clinical decision support (CDS) industry, and based on its findings, recognizes Wolters Kluwer with the 2021 North America Company of the Year Award. The company delivers its solutions - UpToDate®, Lex...

2022-02-03 22:30 2147

Wolters Kluwer Lauded by Frost & Sullivan for Enabling Aligned Decision-making with Its Clinical Decision Support Solutions

Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine in Great Britain*

* Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted)▼ is the first protein-based COVID-19 vaccine authorized inGreat Britain * Novavax and the U.K. Vaccines Taskforce previously announced an agreement for up to 60 million doses * Authorization based on data including an ongoing pivotal Ph...

2022-02-03 21:22 2983

Mentice publishes the company's year-end report for the period January-December 2021

STOCKHOLM, Feb. 3, 2022 /PRNewswire/ -- Continued strength with net sales growth above 30% despite the pandemic Fourth quarter (October-December 2021) * Order intake amounted to 73.7 (73.1) MSEK. * Net sales amounted to 67.7 (45.9) MSEK. * Operating income for the period before depreciation...

2022-02-03 15:37 1984

Phenomenex Celebrates 40-Years of Keeping Scientists Happy & What's to Come

TORRANCE, Calif., Feb. 3, 2022 /PRNewswire/ -- Phenomenex, a global life sciences company that offers analytical chemistry solutions for separation and purification, proudly marks its40th anniversary in 2022 with a new mission statement and several exciting strategic initiatives that will deliver...

2022-02-03 06:49 2423

Zeus Launches PTFE Sub-Lite-Wall® Multi-Lumen Tubing for Steerable Catheters

New Multi-Lumen Tubing Helps Simplify Steerable Catheter Construction, Reduce Manufacturing Steps, and Improve Yields ORANGEBURG, S.C., Feb. 2, 2022 /PRNewswire/ -- Zeus, the global leader in advanced polymer solutions, announced today that it has added PTFE Sub-Lite-Wall ® multi-lumen tubing to ...

2022-02-02 21:00 1848

Conversations with Nobel Prize Winners: The Fondazione Menarini launches their 'Dialogs Beyond Borders' series

FLORENCE, Italy, Feb. 2, 2022 /PRNewswire/ -- Who are the heroes that have inspired the careers of Nobel Prize winners? What difficulties have they encountered and how did they overcome them? Each and every one of us can now delve into the careers and personal lives of some of the biggest names i...

2022-02-02 19:29 2348

Conversations with Nobel Prize Winners: The Fondazione Menarini launches their 'Dialogs Beyond Borders' series

1 ... 231 232 233234235 236 237 ... 553